Navidea Biopharmaceuticals
Last updated: October 31, 2025
CEO Mark Pykett
Country: USA | Funding: $133.8M (+) | Add Funding
Website: http://www.navidea.com/
Navidea Biopharmaceuticals has established a niche in precision medicine. The company focuses on the development and commercialization of diagnostic agents and therapeutics for cancer, autoimmune diseases, dementia, and movement disorders.
Website: http://www.navidea.com/
Navidea Biopharmaceuticals has established a niche in precision medicine. The company focuses on the development and commercialization of diagnostic agents and therapeutics for cancer, autoimmune diseases, dementia, and movement disorders.
